CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
oxygen inhalation therapyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000564
NCT00000564Phase 3Completed
CompareCT.gov

Nocturnal Oxygen Therapy

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Jun 24, 2005

In Brief

A Phase 3 clinical trial evaluating oxygen inhalation therapy for Lung Diseases and 2 related conditions. Completed.

Detailed Summary

To compare the efficacy of long-term use of nocturnal oxygen therapy (12 hours) with that of continuous, low-flow oxygen therapy (24 hours) in patients with chronic hypoxic lung disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Diseases, Lung Diseases, Obstructive, Chronic Obstructive Pulmonary Disease
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
1976197719781979198019811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartJul 1, 1976
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

oxygen inhalation therapyprocedure